开立医疗收盘上涨1.82%，滚动市盈率279.00倍，总市值140.29亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Kaili Medical, indicating a significant decline in revenue and profit in the latest quarter [1][2] - As of July 25, Kaili Medical's stock closed at 32.42 yuan, with a PE ratio of 279.00, marking a new low in 32 days, and a total market capitalization of 14.029 billion yuan [1] - The average PE ratio for the medical device industry is 55.41, with a median of 37.94, positioning Kaili Medical at 118th in the industry ranking [1][2] Group 2 - In the first quarter of 2025, the company reported an operating income of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit of 8.0746 million yuan, down 91.94% [2] - The company's gross profit margin stands at 63.19%, indicating a relatively high profitability despite the decline in revenue and net profit [2] - Kaili Medical specializes in the research, development, production, and sales of medical diagnostic and treatment equipment, with a strong presence in the ultrasound industry and a market share ranking second among domestic manufacturers and tenth globally [1]